Opportunities for Pan-Spectrum Drugs against Herpes
Predicting the Unpredictable
GPCR FlAsH-Walk Mapping: A Leap into the Future

A promising projects portfolio

As of today, CQDM has 34 outstanding research projects for a total of $ 31.8 M invested. These projects are carried out by a network of more than 450 researchers, including close to 60 graduate students, from 52 research institutions (28 public and 24 private) in Quebec, Canada and internationally. These projects cut across about 80 mentors from CQDM’s pharmaceutical companies members.

completed projects